Zaid Fadul, MD, FS, FAAFP, joins for part 2 to discuss what greater adoption of AI across health care ecosystems might mean for pharmacists, patients, and more.
|Slideshows|September 19, 2019
- Drug Topics September 2019
- Volume 163
- Issue 9
Antibiotic Counseling Pearls for the Community Setting
Author(s)Jennifer Gershman, PharmD, CPh
Advertisement
Swipe through the following images for antibiotic counseling tips for patients, from Antimicrobial Stweardship: Protecting Global Health.
Articles in this issue
about 7 years ago
Biosimilars: Some Call for ‘Cautious Optimism’about 7 years ago
Biosimilars Need Access and Cost Examinationsabout 7 years ago
The Latest Autoimmune Disease Treatment Advancesabout 7 years ago
Unique Offerings Increasing Revenueabout 7 years ago
The Growing Problem of Pharmacy Desertsabout 7 years ago
What is a Pharmacy Desert?about 7 years ago
Patient Services are Crucial to the Economics of Pharmacyabout 7 years ago
New Video Marketing Toolsabout 7 years ago
Antimicrobial Stewardship: Protecting Global HealthAdvertisement
Related to this article
For pharmacies competing with CVS and relying on Caremark to serve patients, the prospect of those businesses operating under separate ownership is significant.
Erin Albert of Mark Cuban Cost Plus Drugs explains how the Team Cuban Card offers transparent pricing and fair pay for independent pharmacies.
An abstract from the American Heart Association's Scientific Sessions 2026 reveals the continuous expansion of the GLP-1 medication class.
Matthew Crawford, PhD, of the University of Virginia, and Mario Danek of Qnovia explain what pharmacists can do now and what may come next.
The inquiry puts audit practices, including how pharmacies are selected for audit, proportionality, and pharmacy advocacy in focus.
Nolla Derm’s overseeing physician, Zaid Fadul, MD, FS, FAAFP, discusses the revolutionary AI technology that could transform how health care conducts prescribing practices.
As COVID-19 vaccine guidance shifts, new data suggest vaccinated patients face no greater clot or death risk than with other respiratory infections.
Advertisement
Advertisement
Trending on Drug Topics
1
CVS Plans to Split Off Its Retail Pharmacies, Keeping Specialty Operations
2
Team Cuban Card Includes Transparent Pricing for Cash Patients
3
The Future of HIV PrEP and One Step to Take Tomorrow
4
GLP-1s Outperform Metformin in Prediabetes Risk, MACE
5